Electromed Inc Quick Ratio (ELMD) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Electromed Inc   (NYSEAMER: ELMD)

Electromed Inc 's Quick Ratio

ELMD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2026, Quick Ratio deteriorated to 2.19 above company average Quick Ratio.

Within Medical Equipment & Supplies industry 75 other companies have achieved higher Quick Ratio than Electromed Inc in first quarter 2026. While Quick Ratio total ranking has improved so far during the Q1 2026 to 1287, from total ranking in the fourth quarter 2026 at 1312.

Explain Quick Ratio?
How much Cash & cash equivalents ELMD´s has?
What are ELMD´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ELMD/financial-strength
https://api.csimarket.com/api/v1/companies/ELMD/fundamentals
https://api.csimarket.com/api/v1/companies/ELMD/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
ELMD Quick Ratio (Sep 30 2026)
Q1
(Jun 30 2026)
Q4
(Mar 31 2026)
Q3
(Dec 31 2025)
Q2
(Sep 30 2025)
Q1
Y / Y Current Liabilities Change 17.3 %
Y / Y Cash & cash equivalent Change 12.48 %
Quick Ratio MRQ 2.19
ELMD's Total Ranking # 1287
Seq. Current Liabilities Change -16.67 %
Seq. Cash & cash equivalent Change -22.37 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 76
Healthcare Sector # 464
Overall Market # 1287


Quick Ratio Statistics
High Average Low
4.51 1.67 0.12
(Jun 30 2020)   (Mar 31 2013)




Financial Statements
Electromed Inc 's Current Liabilities $ 7 Millions Visit ELMD's Balance sheet
Electromed Inc 's Cash & cash equivalent $ 16 Millions Visit ELMD's Balance sheet
Source of ELMD's Sales Visit ELMD's Sales by Geography


Cumulative Electromed Inc 's Quick Ratio

ELMD's Quick Ratio for the trailling 12 Months

ELMD Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 5.14 %
Y / Y Cash & cash equivalent TTM Growth 10.23 %
Quick Ratio TTM 1.89
Total Ranking TTM # 3857
Seq. Current Liabilities TTM Growth 3.1 %
Seq. Cash & cash equivalent TTM Growth 2.7 %


On the trailing twelve months basis In Spite of the decline in Current Liabilities in the Q1 2026 to $7.26 millions, cumulative Quick Ratio remained unchanged at 1.89 above the ELMD average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 200 other companies have achieved higher Quick Ratio than Electromed Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2026 from 3113 to 3857.

Explain Quick Ratio?
How much Cash & cash equivalents ELMD´s has?
What are ELMD´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 201
Healthcare Sector # 885
Within the Market # 3857


trailing twelve months Quick Ratio Statistics
High Average Low
3.25 1.57 0.24
(Mar 31 2021)   (Dec 31 2013)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Orasure Technologies Inc  5.90 $ 148.238  Millions$ 25.104  Millions
Perspective Therapeutics Inc   5.09 $ 201.695  Millions$ 39.602  Millions
Clearpoint Neuro Inc   4.68 $ 46.184  Millions$ 9.869  Millions
Cvrx inc   4.67 $ 58.746  Millions$ 12.583  Millions
Dexcom Inc   4.25 $ 964.800  Millions$ 227.000  Millions
Innovative Eyewear Inc   3.86 $ 3.197  Millions$ 0.829  Millions
Sight Sciences Inc   3.84 $ 77.402  Millions$ 20.137  Millions
Alpha Pro Tech Ltd   3.78 $ 25.546  Millions$ 6.750  Millions
Hyperfine Inc   3.60 $ 37.872  Millions$ 10.532  Millions
Profound Medical Corp   3.41 $ 33.343  Millions$ 9.771  Millions
Rxsight Inc   3.40 $ 254.683  Millions$ 74.952  Millions
Omada Health Inc   3.23 $ 243.151  Millions$ 75.379  Millions
Transmedics Group Inc   3.22 $ 492.962  Millions$ 152.857  Millions
Trisalus Life Sciences Inc   3.15 $ 41.057  Millions$ 13.014  Millions
Procept Biorobotics Corporation  3.10 $ 218.369  Millions$ 70.353  Millions
Carlsmed Inc   3.08 $ 56.207  Millions$ 18.237  Millions
Outset Medical Inc   3.07 $ 136.627  Millions$ 44.453  Millions
Sharps Technology Inc   2.82 $ 7.478  Millions$ 2.650  Millions
Edwards Lifesciences Corporation  2.81 $ 4,683.700  Millions$ 1,664.300  Millions
Mimedx Group Inc   2.81 $ 120.791  Millions$ 43.031  Millions
Pulse Biosciences Inc   2.74 $ 36.725  Millions$ 13.395  Millions
Staar Surgical Co  2.73 $ 206.414  Millions$ 75.541  Millions
Medinotec Inc   2.68 $ 2.584  Millions$ 0.963  Millions
Glaukos Corp  2.66 $ 337.478  Millions$ 126.726  Millions
Pulmonx Corporation  2.57 $ 53.245  Millions$ 20.739  Millions
Beta Bionics Inc   2.48 $ 81.551  Millions$ 32.836  Millions
Irhythm Holdings Inc   2.46 $ 560.719  Millions$ 228.025  Millions
Genedx Holdings Corp   2.38 $ 170.118  Millions$ 71.403  Millions
Apyx Medical Corp  2.37 $ 25.777  Millions$ 10.870  Millions
Atricure Inc   2.23 $ 187.031  Millions$ 83.972  Millions

Date modified: 2026-11-11T13:41:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.